COR250117C130000
- 66.20
- 0.000.00%
Cencora Newsroom
Cencora Is Maintained at Equal-Weight by Wells Fargo
Cencora Analyst Ratings
Wells Fargo Adjusts Price Target on Cencora to $237 From $249, Maintains Equalweight Rating
Wells Fargo Maintains Cencora(COR.US) With Hold Rating, Cuts Target Price to $237
Baird Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $302
BofA Securities Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $260
Cencora's Strategic Innovations Enhance Supply Chain Amidst Neutral Market Valuation
J.P. Morgan Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $289
Cencora (COR) Receives a Buy From J.P. Morgan
JPMorgan Adjusts Price Target on Cencora to $289 From $287, Maintains Overweight Rating
TD Cowen Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $288
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $256 to $290
Cencora's Strong US Healthcare Performance and Strategic Acquisition Drive Buy Rating
Barclays Adjusts Cencora Price Target to $290 From $263, Maintains Overweight Rating
Cencora Is Maintained at Outperform by Evercore ISI Group
Cencora Analyst Ratings
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $249 to $292
Mizuho Securities Sticks to Its Hold Rating for Cencora (COR)
Leerink Partners Adjusts Cencora Price Target to $287 From $275
Morgan Stanley Maintains Cencora(COR.US) With Hold Rating, Maintains Target Price $242